Literature DB >> 33381113

The Multiple Functions of B Cells in Chronic HBV Infection.

Ying Cai1, Wenwei Yin1.   

Abstract

Chronic hepatitis B virus (HBV) infection is one of the main causes of liver diseases, of which the natural history and clinical outcomes are associated with the role of B cells. As humoral immune cells, B cells play a critical role in the process of anti-HBV antibody production. In addition, some studies have also characterized other B cell subsets involved in antigen presentation and regulating the immune response beyond antibody secretion. However, not all B cell subsets play a positive role in the immune response to chronic HBV infection, and various B cell subsets jointly mediate persistent HBV infection, tolerance, and liver damage. Thus, we further sought to elucidate the multiple functions of B cells to gain novel insight into the understanding of chronic hepatitis B (CHB) pathogenesis. We also reviewed the current immunotherapies targeting B cells to explore novel therapeutic interventions for the treatment of chronic HBV infection.
Copyright © 2020 Cai and Yin.

Entities:  

Keywords:  B cell; antibody production; antigen presentation; hepatitis B virus; immune regulation; immunotherapy

Year:  2020        PMID: 33381113      PMCID: PMC7767983          DOI: 10.3389/fimmu.2020.582292

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  171 in total

Review 1.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

Review 2.  Neonatal immunology.

Authors:  R L Schelonka; A J Infante
Journal:  Semin Perinatol       Date:  1998-02       Impact factor: 3.300

Review 3.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

4.  Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

Authors:  Aharon Kessel; Tharwat Haj; Regina Peri; Ayelet Snir; Doron Melamed; Edmond Sabo; Elias Toubi
Journal:  Autoimmun Rev       Date:  2011-12-02       Impact factor: 9.754

5.  Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Authors:  Stephan Menne; Daniel B Tumas; Katherine H Liu; Linta Thampi; Dalal AlDeghaither; Betty H Baldwin; Christine A Bellezza; Paul J Cote; Jim Zheng; Randall Halcomb; Abigail Fosdick; Simon P Fletcher; Stephane Daffis; Li Li; Peng Yue; Grushenka H I Wolfgang; Bud C Tennant
Journal:  J Hepatol       Date:  2015-01-02       Impact factor: 25.083

6.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

7.  The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection.

Authors:  Yun Bin Lee; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee
Journal:  J Med Virol       Date:  2015-01-21       Impact factor: 2.327

8.  MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway.

Authors:  Zhiyuan Chen; Yaling Liu; Li Yang; Peng Liu; Yu Zhang; Xiangyang Wang
Journal:  Immunol Lett       Date:  2020-03-16       Impact factor: 3.685

9.  PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Authors:  Loghman Salimzadeh; Nina Le Bert; Charles-A Dutertre; Upkar S Gill; Evan W Newell; Christian Frey; Magdeleine Hung; Nikolai Novikov; Simon Fletcher; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-08-07       Impact factor: 14.808

10.  Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5+CD4+ T Cells.

Authors:  Yu Lei; Tingting Hu; Xiaofei Song; Hong Nie; Min Chen; Weixian Chen; Zhi Zhou; Dazhi Zhang; Huaidong Hu; Peng Hu; Hong Ren
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more
  5 in total

Review 1.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

Review 2.  Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses.

Authors:  Ming-Ling Chang; Yun-Fan Liaw
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 3.  Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma.

Authors:  Marco Y W Zaki; Ahmed M Fathi; Samara Samir; Nardeen Eldafashi; Kerolis Y William; Maiiada Hassan Nazmy; Moustafa Fathy; Upkar S Gill; Shishir Shetty
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.575

Review 4.  Hepatitis B and circadian rhythm of the liver.

Authors:  Ivana Skrlec; Jasminka Talapko
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

Review 5.  Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.

Authors:  Arshi Khanam; Joel V Chua; Shyam Kottilil
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.